AI Rebuilds $50B Pharma Giant’s Thinking, Plan Could Help Every Data-Driven Firm GSK is redesigning pharmaceutical research around AI, from data infrastructure to autonomous scientific agents. Its platforms accelerate hypothesis generation, imaging analysis and drug discovery workflows, offering CIOs a blueprint for enterprise-scale AI transformation in regulated industries.
First seen on govinfosecurity.com
Jump to article: www.govinfosecurity.com/blogs/gsk-ai-driven-science-factory-p-4121
